연구성과로 돌아가기
2023 연구성과별 연구자 정보 (350 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Jung, Sung-Hoon | Jung, SH | 15 | Chonnam Natl Univ, Med Sch, Hwasun, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Shin, Ho-Jin | Shin, HJ | 16 | Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Kim, Do Young | Kim, DY | 17 | Pusan Natl Univ Hosp, Busan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Yi, Jun Ho | Yi, JH | 18 | Chung Ang Univ, Seoul, South Korea | GXZ-8144-2022 | Yi, Jun Ho | ||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Seung-Shin | Lee, SS | 19 | Wonkwang Univ Hosp, Iksan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Do, Young Rok | Do, YR | 20 | Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Yoon, Dok Hyun | Yoon, DH | 21 | Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Cho, Hyungwoo | Cho, H | 22 | Asan Med Ctr, Seoul, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Won-Sik | Lee, WS | 23 | Inje Univ, Busan Paik Hosp, Busan, South Korea | J-5603-2012 | Lee, Jong-Seok | ||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Lee, Ho Sup | Lee, HS | 24 | Kosin Univ, Coll Med, Busan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Uhm, Jieun | Uhm, J | 25 | Hanyang Univ, Coll Med, Seoul, South Korea | KQU-5990-2024 | Uhm, Jieun | ||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Kim, Hyo Jung | Kim, HJ | 26 | Hallym Univ, Coll Med, Anyang, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Jang, Hee Ryeong | Jang, HR | 27 | Kangwon Natl Univ Hosp, Chunchon, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Kim, Sung-Hyun | Kim, SH | 28 | Dong A Univ Hosp, Busan, South Korea | ||||||
| Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | Kim, Kihyun | Kim, K | 29 | Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea | D-5175-2013 | Kim, Kihyun |
페이지 이동: